Rafferty Asset Management
ALDR

Rafferty Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Rafferty Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-144,692
Closed -$2.73M – 923
2019
Q3 		$2.73M Sell
144,692
-13,419
-8% -$153K 0.04% 248
2019
Q2 		$1.86M Buy
158,111
+9,977
+7% +$121K 0.03% 436
2019
Q1 		$2.02M Buy
+148,134
New +$1.92M 0.03% 391

Rafferty Asset Management's ALDR Position: Q4 2019 in Review

Rafferty Asset Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 144,692 shares — an estimated $2.73M sold.

Rafferty Asset Management first reported a position in ALDR in Q1 2019 and held it in 3 quarters. The position peaked at $2.73M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Rafferty Asset Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Rafferty Asset Management sold 144,692 Alder Biopharmaceuticals shares in Q4 2019, an estimated $2.73M.
  • Rafferty Asset Management first reported a position in Alder Biopharmaceuticals in Q1 2019 and held it in 3 quarters.
  • Rafferty Asset Management's Alder Biopharmaceuticals position peaked at $2.73M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Rafferty Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.